| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| Chudnovsky Yekaterina | Director, 10%+ Owner | C/O IMMIX BIOPHARMA, INC., 11400 WEST OLYMPIC BLVD., SUITE 200, LOS ANGELES | /s/ Yekaterina Chudnovsky | 2025-06-23 | 0001979324 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| holding | IMMX | Common Stock | 3.24M | Jun 20, 2025 | Held by GKCC, LLC | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | IMMX | Stock Option (Right to Buy) | Award | $0 | +33K | $0.00 | 33K | Jun 20, 2025 | Common Stock | 33K | $2.24 | Direct | F2 |
| Id | Content |
|---|---|
| F1 | Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. |
| F2 | The Stock Option will vest in twelve (12) equal monthly installments following the date of grant, subject to the Reporting Person's continued service on the Board of Directors. |